Basimglurant — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-02-02 in 4mo
ESTIMATED |
READOUT
An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigemin
Phase 2/3 · Trigeminal Neuralgia |
Noema Pharma AG | Basimglurant |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-06
Sponsor-projected date — can change
|